CGTX
COGNITION THERAPEUTICS INC
Company overview
- Market capitalization
- $89.24M
- Employees
- 14
- Latest publication
- 2026-09-29
About COGNITION THERAPEUTICS INC
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally delivered small molecule to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, which is in Phase 2 clinical studies for the treatment of Alzheimer's disease and Mild Cognitive Impairment, as well as geographic atrophy secondary to dry age-related macular degeneration and dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 250,000USD | 0USD | 0USD |
| Cost Of Revenue | 68,000USD | 61,000USD | 61,000USD | 61,000USD | 45,000USD | 71,000USD | 70,000USD | 67,000USD |
| Gross Profit | -68,000USD | -61,000USD | -61,000USD | -61,000USD | -45,000USD | -71,000USD | -70,000USD | -67,000USD |
| Research Development | 6,052,000USD | 11,147,000USD | 3,773,000USD | 11,481,000USD | 10,786,000USD | 8,154,000USD | 11,392,000USD | 11,577,000USD |
| Selling General Administrative | 2,697,000USD | 2,524,000USD | 2,602,000USD | 2,497,000USD | 2,989,000USD | 2,569,000USD | 3,071,000USD | 3,101,000USD |
| Total Operating Expenses | 8,749,000USD | 13,671,000USD | 6,314,000USD | 13,978,000USD | 13,775,000USD | 10,723,000USD | 14,463,000USD | 14,678,000USD |
| Operating Income | -8,817,000USD | -13,671,000USD | -6,375,000USD | -13,978,000USD | -13,775,000USD | -10,723,000USD | -14,463,000USD | -14,678,000USD |
| Interest Expense | 5,000USD | 5,000USD | 0USD | 3,000USD | 5,000USD | 5,000USD | 3,000USD | 7,000USD |
| Net Interest Income | -5,000USD | -5,000USD | 0USD | -3,000USD | -5,000USD | -5,000USD | -3,000USD | -7,000USD |
| Income Before Tax | -4,570,000USD | -3,343,000USD | -4,930,000USD | -6,734,000USD | -8,480,000USD | -7,842,000USD | -9,937,000USD | -7,041,000USD |
| Net Income | -4,570,000USD | -3,343,000USD | -4,930,000USD | -6,734,000USD | -8,480,000USD | -7,842,000USD | -9,937,000USD | -7,041,000USD |
| Net Income From Continuing Ops | -4,570,000USD | -3,343,000USD | -4,930,000USD | -6,734,000USD | -8,480,000USD | -7,842,000USD | -9,937,000USD | -7,041,000USD |
| Ebit | -4,565,000USD | -3,338,000USD | -4,930,000USD | -6,731,000USD | -8,475,000USD | -7,837,000USD | -9,934,000USD | -7,034,000USD |
| Ebitda | -4,497,000USD | -3,277,000USD | -4,869,000USD | -6,670,000USD | -8,430,000USD | -7,766,000USD | -9,864,000USD | -6,967,000USD |
| Depreciation And Amortization | 68,000USD | 61,000USD | 61,000USD | 61,000USD | 45,000USD | 71,000USD | 70,000USD | 67,000USD |
| Reconciled Depreciation | 68,000USD | 61,000USD | 61,000USD | 61,000USD | 45,000USD | 71,000USD | 70,000USD | 67,000USD |
| Total Other Income Expense Net | 4,247,000USD | 10,328,000USD | 1,445,000USD | 7,244,000USD | 5,295,000USD | 2,881,000USD | 4,526,000USD | 7,637,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 67,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 228,000USD | 266,000USD | 252,000USD | 235,000USD | 98,000USD | 81,000USD |
| Gross Profit | -228,000USD | -266,000USD | -252,000USD | -235,000USD | -98,000USD | -81,000USD |
| Research Development | 37,187,000USD | 41,676,000USD | 37,196,000USD | 30,324,000USD | 12,887,000USD | 14,379,000USD |
| Selling General Administrative | 10,612,000USD | 12,290,000USD | 13,528,000USD | 13,227,000USD | 4,520,000USD | 3,452,000USD |
| Total Operating Expenses | 47,799,000USD | 53,966,000USD | 50,724,000USD | 43,316,000USD | 17,309,000USD | 4,667,000USD |
| Operating Income | -47,799,000USD | -53,966,000USD | -50,724,000USD | -43,551,000USD | -17,407,000USD | -17,831,000USD |
| Interest Expense | 13,000USD | 25,000USD | 27,000USD | 28,000USD | 1,751,000USD | 1,024,000USD |
| Net Interest Income | -13,000USD | -25,000USD | -28,000USD | -28,000USD | -1,751,000USD | -1,024,000USD |
| Income Before Tax | -23,487,000USD | -33,971,000USD | -25,788,000USD | -21,397,000USD | -7,839,000USD | -4,842,000USD |
| Net Income | -23,487,000USD | -33,971,000USD | -25,788,000USD | 757,000USD | -10,072,000USD | -6,953,000USD |
| Net Income From Continuing Ops | -23,487,000USD | -33,971,000USD | -22,829,000USD | -43,614,000USD | -7,839,000USD | -4,842,000USD |
| Ebit | -23,474,000USD | -33,946,000USD | -25,761,000USD | -21,369,000USD | -6,088,000USD | -3,818,000USD |
| Ebitda | -23,246,000USD | -33,680,000USD | -25,509,000USD | -21,134,000USD | -5,990,000USD | -3,737,000USD |
| Depreciation And Amortization | 228,000USD | 266,000USD | 252,000USD | 235,000USD | 98,000USD | 81,000USD |
| Reconciled Depreciation | 228,000USD | 266,000USD | 246,000USD | 235,000USD | 98,000USD | 81,000USD |
| Total Other Income Expense Net | 24,312,000USD | 19,995,000USD | 24,936,000USD | 22,154,000USD | 9,568,000USD | 12,989,000USD |
| Selling And Marketing Expenses | — | — | 252,000USD | — | — | — |
| Income Tax Expense | — | — | — | -22,154,000USD | 2,233,000USD | 2,111,000USD |
| Non Operating Income Net Other | — | — | — | -35,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -21,397,000USD | -12,073,000USD | -8,762,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | -13,164,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 36,140,000USD | 48,390,000USD | 43,395,000USD | 19,622,000USD | 23,500,000USD | 30,234,000USD | 27,579,000USD | 34,369,000USD |
| Other Current Assets | 1,027,000USD | 1,068,000USD | 1,160,000USD | 2,021,000USD | 1,660,000USD | 1,860,000USD | 1,450,000USD | 1,918,000USD |
| Total Liab | 6,229,000USD | 14,119,000USD | 6,866,000USD | 12,593,000USD | 11,230,000USD | 11,484,000USD | 13,097,000USD | 11,360,000USD |
| Total Stockholder Equity | 29,911,000USD | 34,271,000USD | 36,529,000USD | 7,029,000USD | 12,270,000USD | 18,750,000USD | 14,482,000USD | 23,009,000USD |
| Other Current Liab | 1,694,000USD | 11,995,000USD | 3,923,000USD | 9,372,000USD | 7,708,000USD | 7,620,000USD | 9,505,000USD | 6,064,000USD |
| Common Stock | 90,000USD | 90,000USD | 88,000USD | 65,000USD | 62,000USD | 60,000USD | 41,000USD | 40,000USD |
| Capital Stock | 90,000USD | 90,000USD | 88,000USD | 65,000USD | 62,000USD | 60,000USD | 41,000USD | 40,000USD |
| Retained Earnings | -203,217,000USD | -198,647,000USD | -195,304,000USD | -190,374,000USD | -183,640,000USD | -175,160,000USD | -167,318,000USD | -157,381,000USD |
| Cash | 31,130,000USD | 37,000,000USD | 39,823,000USD | 10,743,000USD | 16,428,000USD | 25,009,000USD | 22,011,000USD | 28,533,000USD |
| Cash And Short Term Investments | 31,130,000USD | 37,000,000USD | 39,823,000USD | 10,743,000USD | 16,428,000USD | 25,009,000USD | 22,011,000USD | 28,533,000USD |
| Total Current Assets | 35,814,000USD | 47,991,000USD | 42,883,000USD | 19,049,000USD | 22,866,000USD | 29,555,000USD | 26,830,000USD | 33,550,000USD |
| Total Current Liabilities | 6,053,000USD | 13,924,000USD | 6,654,000USD | 12,364,000USD | 10,950,000USD | 11,142,000USD | 12,705,000USD | 10,920,000USD |
| Current Deferred Revenue | 220,000USD | 367,000USD | 1,736,000USD | 1,982,000USD | 1,066,000USD | 1,066,000USD | 1,117,000USD | 1,453,000USD |
| Net Debt | -30,665,000USD | -36,362,000USD | -39,443,000USD | -10,275,000USD | -15,793,000USD | -24,195,000USD | -21,431,000USD | -27,724,000USD |
| Short Term Debt | 289,000USD | 443,000USD | 168,000USD | 239,000USD | 355,000USD | 472,000USD | 188,000USD | 369,000USD |
| Short Long Term Debt | 194,000USD | 307,000USD | — | 41,000USD | 161,000USD | 279,000USD | — | 185,000USD |
| Short Long Term Debt Total | 465,000USD | 638,000USD | 380,000USD | 468,000USD | 635,000USD | 814,000USD | 580,000USD | 809,000USD |
| Net Receivables | 3,657,000USD | 9,923,000USD | 1,900,000USD | 6,285,000USD | 4,778,000USD | 2,686,000USD | 3,369,000USD | 3,099,000USD |
| Accounts Payable | 3,850,000USD | 1,119,000USD | 827,000USD | 771,000USD | 1,821,000USD | 1,984,000USD | 1,895,000USD | 3,034,000USD |
| Property Plant Equipment Net | 326,000USD | 399,000USD | 512,000USD | 573,000USD | 634,000USD | 679,000USD | 749,000USD | 819,000USD |
| Property Plant Equipment Gross | 326,000USD | 586,000USD | 512,000USD | 573,000USD | 634,000USD | 1,835,000USD | 749,000USD | 819,000USD |
| Common Stock Shares Outstanding | 89,191,313shares | 88,904,161shares | 77,951,513shares | 63,690,945shares | 61,828,149shares | 46,431,346shares | 40,418,065shares | 40,062,954shares |
| Non Current Assets Total | 326,000USD | 399,000USD | 512,000USD | 573,000USD | 634,000USD | 679,000USD | 749,000USD | 819,000USD |
| Non Current Liabilities Total | 176,000USD | 195,000USD | 211,999USD | 229,000USD | 280,000USD | 342,000USD | 392,000USD | 440,000USD |
| Net Working Capital | 29,761,000USD | 34,067,000USD | 36,229,000USD | 6,685,000USD | 11,916,000USD | 18,413,000USD | 14,125,000USD | 22,630,000USD |
| Unclassified Equity | 232,948,000USD | 232,738,000USD | 231,657,000USD | 197,273,000USD | 195,786,000USD | 193,790,000USD | 181,718,000USD | 180,310,000USD |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 48,390,000USD | 30,234,000USD | 35,163,000USD | 50,425,000USD | 59,137,000USD | 7,119,000USD | 7,459,000USD |
| Other Current Assets | 1,258,000USD | 1,860,000USD | 3,019,000USD | 2,413,000USD | 11,000USD | 567,000USD | 29,000USD |
| Total Liab | 14,119,000USD | 11,484,000USD | 10,689,000USD | 10,176,000USD | 7,864,000USD | 75,303,000USD | 65,881,000USD |
| Total Stockholder Equity | 34,271,000USD | 18,750,000USD | 24,474,000USD | 40,249,000USD | 51,273,000USD | -68,184,000USD | -58,422,000USD |
| Other Current Liab | 11,995,000USD | 7,620,000USD | 4,055,000USD | 2,094,000USD | 3,696,000USD | 1,247,000USD | 1,000USD |
| Common Stock | 90,000USD | 60,000USD | 32,000USD | 29,000USD | 22,000USD | 1,000USD | 1,000USD |
| Capital Stock | 90,000USD | 60,000USD | 32,000USD | 29,000USD | 22,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -198,647,000USD | -175,160,000USD | -141,189,000USD | -115,401,000USD | -94,004,000USD | -68,220,000USD | -58,239,000USD |
| Cash | 36,810,000USD | 25,009,000USD | 29,922,000USD | 41,562,000USD | 54,721,000USD | 5,189,000USD | 2,890,000USD |
| Cash And Short Term Investments | 36,810,000USD | 25,009,000USD | 29,922,000USD | 41,562,000USD | 54,721,000USD | 5,189,000USD | 2,890,000USD |
| Total Current Assets | 47,991,000USD | 29,555,000USD | 34,222,000USD | 47,647,000USD | 58,992,000USD | 6,908,000USD | 7,160,000USD |
| Total Current Liabilities | 13,924,000USD | 11,142,000USD | 10,169,000USD | 7,795,000USD | 7,864,000USD | 3,250,000USD | 3,683,000USD |
| Current Deferred Revenue | 367,000USD | 1,066,000USD | 1,701,000USD | 1,702,000USD | 753,000USD | — | 1,321,000USD |
| Net Debt | -36,172,000USD | -24,195,000USD | -28,684,000USD | -40,084,000USD | -54,721,000USD | 7,663,000USD | 4,011,000USD |
| Short Term Debt | 443,000USD | 472,000USD | 718,000USD | 783,000USD | 753,000USD | — | 4,000USD |
| Short Long Term Debt | 307,000USD | 279,000USD | 544,000USD | 634,000USD | — | — | — |
| Short Long Term Debt Total | 638,000USD | 814,000USD | 1,238,000USD | 1,478,000USD | — | 12,852,000USD | 6,901,000USD |
| Net Receivables | 9,923,000USD | 2,686,000USD | 1,281,000USD | 3,672,000USD | 2,266,000USD | 1,152,000USD | 4,124,000USD |
| Accounts Payable | 1,119,000USD | 1,984,000USD | 3,695,000USD | 3,216,000USD | 4,168,000USD | 2,003,000USD | 2,357,000USD |
| Property Plant Equipment Net | 399,000USD | 679,000USD | 941,000USD | 1,046,000USD | 145,000USD | 211,000USD | 299,000USD |
| Property Plant Equipment Gross | 586,000USD | 1,835,000USD | 1,990,000USD | 1,999,000USD | 1,015,000USD | 988,000USD | 978,000USD |
| Common Stock Shares Outstanding | 72,766,983shares | 39,730,148shares | 30,029,087shares | 28,991,548shares | 22,230,032shares | 21,936,629shares | 21,936,629shares |
| Non Current Assets Total | 399,000USD | 679,000USD | 941,000USD | 2,778,000USD | 145,000USD | 211,000USD | 299,000USD |
| Non Current Liabilities Total | 195,000USD | 342,000USD | 520,000USD | 2,381,000USD | 4,168,000USD | 72,053,000USD | 62,198,000USD |
| Net Working Capital | 34,067,000USD | 18,413,000USD | 24,053,000USD | 39,852,000USD | 51,128,000USD | 3,658,000USD | 3,477,000USD |
| Unclassified Equity | 232,738,000USD | 193,790,000USD | 165,794,000USD | 155,791,000USD | 145,431,000USD | — | — |
| Other Assets | — | — | 1USD | — | — | 0USD | 0USD |
| Accumulated Other Comprehensive Income | — | — | -195,000USD | -199,000USD | -198,000USD | -187,000USD | -185,000USD |
| Non Currrent Assets Other | — | — | -1USD | 1,732,000USD | — | — | — |
| Non Current Liabilities Other | — | — | — | 1,686,000USD | — | — | — |
| Net Tangible Assets | — | — | — | 40,249,000USD | 51,273,000USD | -68,184,000USD | -58,422,000USD |
| Inventory | — | — | — | — | 1,994,000USD | 544,000USD | 117,000USD |
| Unclassified Current Liabilities | — | — | — | — | -1,506,000USD | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | 4,168,000USD | 55,370,000USD | 52,927,000USD |
| Other Liab | — | — | — | — | — | 3,831,000USD | 2,374,000USD |
| Long Term Debt | — | — | — | — | — | 12,852,000USD | 6,897,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,570,000USD | -3,343,000USD | -4,930,000USD | -6,734,000USD | -8,480,000USD | -7,842,000USD | -9,937,000USD | -7,041,000USD |
| Depreciation | 68,000USD | 61,000USD | 61,000USD | 61,000USD | 45,000USD | 71,000USD | 70,000USD | 67,000USD |
| Stock Based Compensation | 330,000USD | 358,000USD | 522,000USD | 621,000USD | 586,000USD | 534,000USD | 896,000USD | 1,147,000USD |
| Other Non Cash Items | 5,000USD | 41,000USD | 522,000USD | — | 586,000USD | — | 1,966,000USD | 1,794,000USD |
| Change To Account Receivables | 6,266,000USD | -8,023,000USD | 4,385,000USD | -1,507,000USD | -2,092,000USD | 683,000USD | -270,000USD | -2,238,000USD |
| Change In Working Capital | -1,375,000USD | -554,000USD | -1,304,000USD | 429,000USD | -2,028,000USD | -1,145,000USD | 2,120,000USD | -170,000USD |
| Total Cash From Operating Activities | -5,542,000USD | -3,437,000USD | -5,651,000USD | -5,623,000USD | -9,877,000USD | -8,382,000USD | -6,851,000USD | -5,997,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | -1,000USD | -3,000USD | -3,000USD |
| Free Cash Flow | -5,542,000USD | -3,437,000USD | -5,651,000USD | -5,623,000USD | -9,877,000USD | -8,383,000USD | -6,851,000USD | -6,000,000USD |
| Net Borrowings | -113,000USD | -74,000USD | -41,000USD | -120,000USD | -118,000USD | -195,000USD | -185,000USD | — |
| Total Cash From Financing Activities | -233,000USD | 605,000USD | 33,917,000USD | 752,000USD | 1,296,000USD | 11,381,000USD | 329,000USD | -138,000USD |
| Issuance Of Capital Stock | 0USD | 750,000USD | 33,929,000USD | 877,000USD | 1,460,000USD | 11,576,000USD | 497,000USD | 0USD |
| Change In Cash | -5,775,000USD | -2,823,000USD | 28,266,000USD | -4,871,000USD | -8,581,000USD | 2,998,000USD | -6,522,000USD | -6,138,000USD |
| Begin Period Cash Flow | 37,000,000USD | 39,823,000USD | 11,557,000USD | 16,428,000USD | 25,009,000USD | 22,011,000USD | 28,533,000USD | 34,671,000USD |
| End Period Cash Flow | 31,225,000USD | 37,000,000USD | 39,823,000USD | 11,557,000USD | 16,428,000USD | 25,009,000USD | 22,011,000USD | 28,533,000USD |
| Other Cashflows From Financing Activities | -164,000USD | -77,000USD | -36,000USD | -5,000USD | -46,000USD | — | 17,000USD | -22,000USD |
| Total Cashflows From Investing Activities | — | 9,000USD | — | — | — | -1,000USD | — | -3,000USD |
| Investments | — | — | 0USD | 0USD | 0USD | -1,000USD | 0USD | -3,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 106,000USD | -22,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | -3,000USD | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -1,966,000USD | -1,794,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|
| Net Income | -23,487,000USD | -33,971,000USD | -25,788,000USD | -11,716,000USD |
| Depreciation | 228,000USD | 266,000USD | 252,000USD | 93,000USD |
| Stock Based Compensation | 2,087,000USD | 3,748,000USD | 4,354,000USD | 5,183,000USD |
| Other Non Cash Items | 41,000USD | 195,000USD | 318,000USD | -33,000USD |
| Change To Account Receivables | -7,237,000USD | -1,405,000USD | 2,391,000USD | -1,114,000USD |
| Change In Working Capital | -3,457,000USD | 1,288,000USD | 4,846,000USD | 2,842,000USD |
| Total Cash From Operating Activities | -24,588,000USD | -28,474,000USD | -16,018,000USD | -3,631,000USD |
| Capital Expenditures | 0USD | -4,000USD | -147,000USD | -27,000USD |
| Free Cash Flow | -24,588,000USD | -28,478,000USD | -16,165,000USD | -3,658,000USD |
| Total Cashflows From Investing Activities | 9,000USD | -4,000USD | -147,000USD | -27,000USD |
| Net Borrowings | -353,000USD | -739,000USD | -811,000USD | -268,000USD |
| Total Cash From Financing Activities | 36,570,000USD | 23,565,000USD | 4,521,000USD | 53,201,000USD |
| Issuance Of Capital Stock | 37,016,000USD | 24,350,000USD | 8,038,000USD | 44,217,000USD |
| Change In Cash | 11,991,000USD | -4,913,000USD | -11,640,000USD | 49,532,000USD |
| Begin Period Cash Flow | 25,009,000USD | 29,922,000USD | 41,562,000USD | 5,189,000USD |
| End Period Cash Flow | 37,000,000USD | 25,009,000USD | 29,922,000USD | 54,721,000USD |
| Other Cashflows From Investing Activities | 9,000USD | -4,000USD | — | -27,000USD |
| Other Cashflows From Financing Activities | -164,000USD | -46,000USD | -147,000USD | 9,252,000USD |
| Investments | — | -4,000USD | -127,000USD | -27,000USD |
| Change To Inventory | — | — | -2,440,000USD | 1,114,000USD |
| Unclassified Financing Cash Flow | — | — | -2,559,000USD | — |
| Change To Liabilities | — | — | — | 2,165,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.